David A. Bristol
Direttore/Membro del Consiglio presso HCF Enterprises, Inc.
Posizioni attive di David A. Bristol
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HCF Enterprises, Inc. | Direttore/Membro del Consiglio | - | - |
| Sentinel Private Equity XVI Fund | Direttore/Membro del Consiglio | - | - |
Storia della carriera di David A. Bristol
Precedenti posizioni note di David A. Bristol
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Exxon Co. USA | Corporate Officer/Principal | 02/01/1991 | 02/01/1991 |
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Direttore/Membro del Consiglio | 28/07/2011 | - |
Formazione di David A. Bristol
| Brown University | Undergraduate Degree |
| The University of Texas at Austin | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
| HCF Enterprises, Inc. | |
| Exxon Co. USA | |
| Sentinel Private Equity XVI Fund |
- Borsa valori
- Insiders
- David A. Bristol
- Esperienza
